Micelle-Based Adjuvants for Subunit Vaccine Delivery
AbstractIn the development of subunit vaccines with purified or recombinant antigens for cancer and infectious diseases, the design of improved and safe adjuvants able to efficiently target the antigen presenting cells, such as dendritic cells, represents a crucial challenge. Nanoparticle-based antigen delivery systems have been identified as an innovative strategy to improve the efficacy of subunit vaccines. Among them, self-assembled micellar nanoparticles from amphiphilic (macro)molecules have recently emerged as promising candidates. In this short review, we report on the recent research findings highlighting the versatility and potential of such systems in vaccine delivery. View Full-Text
Share & Cite This Article
Trimaille, T.; Verrier, B. Micelle-Based Adjuvants for Subunit Vaccine Delivery. Vaccines 2015, 3, 803-813.
Trimaille T, Verrier B. Micelle-Based Adjuvants for Subunit Vaccine Delivery. Vaccines. 2015; 3(4):803-813.Chicago/Turabian Style
Trimaille, Thomas; Verrier, Bernard. 2015. "Micelle-Based Adjuvants for Subunit Vaccine Delivery." Vaccines 3, no. 4: 803-813.